Effects of Pharmaceutical Promotion on Adherence to the Treatment Guidelines for Depression
暂无分享,去创建一个
Ernst R Berndt | Julie M Donohue | Meredith Rosenthal | E. Berndt | M. Rosenthal | A. Epstein | R. Frank | J. Donohue | Richard G Frank | Arnold M Epstein
[1] A. F. Holmer,et al. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. , 1999, JAMA.
[2] F. Goodwin,et al. The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis. , 1988, The American journal of psychiatry.
[3] Broadhead We. Misdiagnosis of depression. Physicians contribute to the stigmatization of mental illness. , 1994 .
[4] K. Rost,et al. The deliberate misdiagnosis of major depression in primary care. , 1994, Archives of family medicine.
[5] M. Thase,et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. , 1997, JAMA.
[6] W. Katon,et al. A randomized trial of relapse prevention of depression in primary care. , 2001, Archives of general psychiatry.
[7] Michael J. Campbell,et al. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial , 1999, BMJ.
[8] C. Sherbourne,et al. Long-term effectiveness of disseminating quality improvement for depression in primary care. , 2001, Archives of general psychiatry.
[9] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[10] H Aberg,et al. PATIENT COMPLIANCE , 1973, MMW, Munchener medizinische Wochenschrift.
[11] G. Urban,et al. Information, marketing, and pricing in the U.S. antiulcer drug market. , 1995, The American economic review.
[12] S. Wolfe. Direct-to-consumer advertising--education or emotion promotion? , 2002, The New England journal of medicine.
[13] J. Avorn,et al. Predictors of Physician Prescribing Change in an Educational Experiment to Improve Medication Use , 1987, Medical care.
[14] A. Holmer. Direct-to-consumer advertising--strengthening our health care system. , 2002, The New England journal of medicine.
[15] C. Sherbourne,et al. The quality of care for depressive and anxiety disorders in the United States. , 2001, Archives of general psychiatry.
[16] T. Croghan,et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. , 1998, Archives of general psychiatry.
[17] J Ormel,et al. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. , 1994, JAMA.
[18] K. Wells,et al. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study. , 1994, The American journal of psychiatry.
[19] M. Ziegler,et al. The accuracy of drug information from pharmaceutical sales representatives. , 1995, JAMA.
[20] C. Sherbourne,et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. , 2000, JAMA.
[21] N. Duan,et al. Two-year effects of quality improvement programs on medication management for depression. , 2001, Archives of general psychiatry.
[22] J Lexchin,et al. What information do physicians receive from pharmaceutical representatives? , 1997, Canadian family physician Medecin de famille canadien.
[23] J. Rizzo,et al. Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs* , 1999, The Journal of Law and Economics.
[24] A. Rush,et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. , 1998, Archives of general psychiatry.
[25] J. Pyne,et al. The relationship between quality and outcomes in routine depression care. , 2001, Psychiatric services.
[26] K Kroenke,et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. , 1995, JAMA.
[27] S B Soumerai,et al. Principles of educational outreach ('academic detailing') to improve clinical decision making. , 1990, JAMA.
[28] T. Croghan,et al. Use of claims data for research on treatment and outcomes of depression care. , 1999, Medical care.
[29] Olga V. Demler,et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.
[30] W. Broadhead. Misdiagnosis of depression. Physicians contribute to the stigmatization of mental illness. , 1994, Archives of family medicine.
[31] M. Hollon. Direct-To-Consumer Marketing of Prescription Drugs , 2004 .
[32] M. Kyle,et al. Deregulating Direct‐to‐Consumer Marketing of Prescription Drugs: Effects on Prescription and Over‐the‐Counter Product Sales* , 2002, The Journal of Law and Economics.
[33] D. Blumenthal,et al. Consumers' reports on the health effects of direct-to-consumer drug advertising. , 2003, Health affairs.
[34] M. O’Hara,et al. Description and evaluation of the Iowa Depression Awareness, Recognition, and Treatment Program. , 1996, The American journal of psychiatry.
[35] M. Hollon. Direct-to-consumer marketing of prescription drugs: creating consumer demand. , 1999, JAMA.